John A. Boockvar

Neural stem cell biology may be well suited for improving brain tumor therapies.

Constitutive EGFR signaling confers a motile phenotype to neural stem cells.

Experimental traumatic brain injury modulates the survival, migration, and terminal phenotype of transplanted epidermal growth factor receptor-activated neural stem cells.

Dural cavernous angioma of the posterior sagittal sinus: case report.

The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer?

Use of human neural tissue for the generation of progenitors.

Long-term expansion of adult human brain subventricular zone precursors.

New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans.

Brain tumor stem cells: will understanding a new paradigm lead to improved therapies?

Stem cell migration in a novel model to study pediatric brain tumors.

Disease-specific induced pluripotent stem cells.

Stem cell populated implanted trachea.

The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells.

Stem cell based growth factory delivery to the injured spinal cord.

Interstitial infusion of erlotinib in the rodent brain.

Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.

Forcing tumor stem cells to an end.

High-viscosity polymethylmethacrylate cement for endoscopic anterior cranial base reconstruction.

Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection.

Neural stem cells: targeting glioma in 3-dimensions.

Results and risk factors for recurrence following single-level tubular lumbar microdiscectomy.

Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors?

EGFR signaling is differentially activated in patient-derived glioblastoma stem cells.

Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.

Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction.

Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.

Neural stem cells and glioma stem-like cells respond differently to chemotherapeutic drugs: selectivity at the cellular level.

Glioblastoma Stem-Like Cells-Biology and Therapeutic Implications.

Direct conversion of human fibroblasts to functional neurons in one step.

Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme.

The Contribution of Notch Signaling to Glioblastoma via Activation of Cancer Stem Cell Self-renewal: The Role of the Endothelial Network.

Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia.